nanopath
1 known investors
Nanopath is developing a molecular diagnostic platform designed for point-of-care disease diagnosis, with a focus on women's health. The company works to commercialize novel diagnostic technologies aimed at improving human health.
Investors · 1
Frequently asked questions
- What does nanopath do?
- Nanopath is developing a molecular diagnostic platform designed for point-of-care disease diagnosis, with a focus on women's health. The company works to commercialize novel diagnostic technologies aimed at improving human health.
- Who are nanopath's investors?
- nanopath's investors include Undeterred Capital.